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P eriarticular osteoporosis,  bone destruction (bone erosion),  and decreased systemic bone volume 
are representative characteristics of bone lesions in 
patients with rheumatoid arthritis (RA) [1 , 2].  Even in 
patients with low-severity RA whose condition is main-
tained on biological disease-modifying antirheumatic 
drugs (bDMARDs),  the persistence of local inflamma-
tion in peripheral joints such as finger joints was associ-
ated with alteration of the trabecular compartment [3].  
For the amelioration of synovitis and arthritis,  metho-
trexate (MTX),  an antifolate-type antimetabolite,  along 
with tumor necrosis factor (TNF) inhibitors,  anti-inter-
leukin (IL)-6 receptor antibodies,  and modulated T-cell 
costimulatory inhibitors are currently prescribed in 
clinical practices.  These drugs also showed an inhibi-
tory effect on bone destruction in periarticular lesions 
[4-6].  It was reported that TNF inhibitors improved the 
upregulation of serum bone resorption-related markers 
such as the receptor activator of nuclear factor kappa-Β 
ligand (RANKL) and crosslinked telopeptide of type I 
collagen (CTX-1) [7].
Most importantly,  RA affects hip joints,  and in 
some cases of destructive RA,  total hip arthroplasty is 
still required [8].  The pathogenesis and microstruc-
tures in subcapital cancellous bone in RA affecting the 
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Rheumatoid arthritis (RA) affects the hip joints.  The microarchitecture of the cancellous bone in RA-affected 
hip joints has been unclear.  Here we investigated the bone metabolism changes in the subcapital cancellous 
bone of destructive hips of RA patients (n = 26 patients; 28 hip joints) which were classified by Larsen grade on 
X-ray into the groups: destructive hip (Des) (Larsen grade IV,  n = 18) and neck fracture (Fx) (Larsen grade 0 or 
1,  n = 10).  The femoral heads of the Des-group showed significantly higher trabecular thickness versus those of 
the Fx-group (179 ± 30.8 vs. 151 ± 23.5 μm,  p= 0.02).  The Des-group had significantly higher osteoid volume/
tissue volume (OV/TV) and osteoid volume/bone volume (OV/BV) ratios than the Fx-group (OV/TV:  
0.72 ± 0.70% vs. 0.27 ± 0.32%,  p= 0.028; OV/BV: 2.96 ± 2.85% vs. 1.24 ± 1.31%,  p= 0.039).  The osteoblast and 
osteoclast surface areas of the Des-group were remarkably higher than those of the Fx-group (9.80 ± 10.9 vs. 
0.15 ± 0.15%,  p= 0.0005; 0.34 ± 0.48 vs. 0.06 ± 0.06%,  p= 0.0285,  respectively).  The T-scores of hip (femoral 
neck) bone mineral density (BMD) of the Fx-group were significantly lower versus those of the Des-group 
(−3.1 ± 0.76 vs. −1.6 ± 1.17,  p< 0.01).  Increased osteoid and resorption parameters and higher femoral neck 
BMD demonstrate a high bone-turnover state in response to destructive changes in the hips of RA patients.
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hip joints have been unclear.  Bone histomorphome-
try — a bone microarchitecture characterization 
method — can be used to analyze bone tissue on the 
cellular level and quantitatively evaluate the bone 
metabolism and its dynamics.  Generally,  the human 
iliac bone has been used for bone histomorphometry 
[9],  but the femoral head was used in several past stud-
ies for assessments of the microarchitecture of bone 
tissue affected by osteoporosis or osteoarthritis in clini-
cal settings [10-12].  The femoral head is the anatomical 
zone most affected by the pathologies in question and is 
considered the most reliable sampling zone.  However,  
no study has yet demonstrated the changes in bone 
metabolism in the cancellous bone of femoral heads 
affected by RA.  We conducted the present study to 
investigate how the bone metabolism changes in cancel-
lous bones of destructive femoral heads in patients with 
RA.  For this investigation,  we evaluated the findings of 
bone histomorphometry of cancellous bone in the fem-
oral heads of RA patients with destructive changes and 
compared the findings with those of RA patients with 
femoral neck fractures.
Patients and Methods
We enrolled Japanese 26 patients (28 hips,  including 
2 bilateral cases) between September 2009 and August 
2015.  All patients met the 2010 American College of 
Rheumatology/European League Against Rheumatism 
(ACR/EULAR) criteria for RA and were under treat-
ment with MTX and/or bDMARDs at the time of a total 
hip arthroplasty (THA) for destructive hip secondary to 
RA or a femoral head replacement (FHR) following a 
femoral neck fracture.  Just after the THA or FHR,  the 
osteotomized femoral heads were extracted and sub-
jected to bone histomorphometry.
We divided the femoral heads into two groups 
depending on the location of the destruction of the hip 
joints.  Femoral heads showing Larsen grade IV defor-
mity (18 hips) on X-ray were allocated to the destruc-
tive (Des) group,  and all of the femoral neck fracture 
cases showing Larsen grade 0 (9 hips) or I (1 hip) on 
X-ray were allocated to the fracture (Fx) group.  There 
were no Larsen grade II,  III,  or V cases.  One case in 
the Des-group was complicated with idiopathic osteo-
necrosis of the femoral head.  The evaluated items were 
as follows: the duration of RA (from diagnosis to the 
THA or FHR),  the patient’s age at the time of surgery,  
the use and average doses of prednisolone (PSL) and 
MTX,  the specific history of bDMARD use,  osteopo-
rosis medications (specially bisphosphonates),  and the 
Disease Activity Score-28 C-Reactive Protein (DAS28-
CRP) values [3].  Serum CRP,  rheumatoid factor (RF),  
and matrix metalloproteinase-3 (MMP-3) were assessed 
at the time of hip surgery.  In addition,  the bone min-
eral density (BMD) of the hips on the contralateral side 
was measured using dual energy X-ray absorptiometry 
(DXA) (Hologic,  Tokyo),  and the T-scores of the fem-
oral neck sites were evaluated around the hip surgery 
area for each patient.
Bone histomorphometry. The osteotomized fem-
oral heads were pre-stained for 72 h using Villanueva 
bone stain.  The specimens were dehydrated,  defatted,  
and embedded with methyl methacrylate and stored at 
37°C until they were fully polymerized.  Embedded 
biopsy samples were subsequently sectioned at 5 μm 
thick on a microtome (Leica RM2255; Leica,  Nussloch,  
Germany).
A region of interest (ROI) was set up in a 20-mm2 
region at the center of the femoral head in the maximal 
plane of the tissue section (Fig. 1).  The central region 
was selected so that the influence of the degeneration of 
the hip articular cartilage could be ignored.  Normal 
light and fluorescent microscopic findings were evalu-
ated and compared between the Des- and Fx-groups.  
Bone histomorphometric parameters were measured 
with an epifluorescence microscope-based system 
(Olympus BX50; Olympus America,  Center Valley,  
PA,  USA) connected to an Epson computer (Shinshu 
Seiki Co.,  Nagano,  Japan).
Bone histomorphometric parameters. The spec-
imen from each case stained with Villanueva bone stain 
was observed under a light microscope,  and trabecular 
bones,  osteoids,  and osteoclasts were measured.  The 
bone histomorphometric parameters were based on a 
previous report [13].  The scheme of these parameters is 
provided as Fig. 2.  As bone volume parameters,  the 
bone volume/issue volume (BV/TV),  trabecular thick-
ness (Tb.Th),  and wall thickness (W.Th) were mea-
sured.  As osteoid parameters (i.e.,  bone formation 
parameters),  the osteoid volume/tissue volume (OV/
TV),  osteoid volume/bone volume (OV/BV),  osteoid 
surface (OS/BS),  osteoid thickness (O.Th), and osteo-
blast surface (Ob.S) were measured.  As bone resorption 
parameters,  the eroded surface/bone surface (ES),  
osteoclast surface (Oc.S/BS),  and fibrosis volume (Fb.
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V/TV) were measured.
Statistical analysis. An unpaired t-test (Student 
or Welch) or Mann-Whitney test was performed,  and a 
p-value < 0.05 was considered significant.  We per-
formed a correlation analysis to examine the associa-
tion between the BMD of the femoral neck and each 
bone morphometric parameter,  and p-values < 0.05 
were considered significant.  GraphPad Prism 6J soft-
ware (GraphPad Software,  San Diego,  CA,  USA) was 
used to perform all statistical analyses.
Ethics. The clinical study was approved by the 
institutional review board of Niigata University (2018-
0377; the clinical study for patients with RA using 
Niigata University Orthopedic Surgery Rheumatoid 
Arthritis Database: NOSRAD).  Written informed con-
sent was obtained from each enrolled patient.
Results
The 26 patients (28 hips) were 3 men (3 hips) and 23 
women (25 hips); average age 66.4 ± 12.5 years (39-87 
years).  The average RA disease duration was 14.8 ± 12.7 
years (0.3-48 years).  Bisphosphonates and PSL were 
used by 38% (n = 10) and 50% (n = 13) of the patients,  
respectively.  The average dose of PSL was 2.6 ± 3.8 mg/
day.  MTX was used by 11 patients (42%) with the mean 
dosage of 2.7 mg/week; bDMARDs were used in 14 
cases (54%).  No significant difference was detected 
between the Des-group (18 hips) and Fx-group 
(10 hips) regarding patient age; RA duration; rates of 
bisphosphonate,  PSL,  MTX,  and bDMARD use; or 
the average dose of PSL (3.2 ± 4.0 mg/day vs. 
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Fig. 1　 Region of interest for the bone histomorphometry of the femoral heads.  Bar: =1 mm.
Tb.Th
O.Th
Fig. 2　 Scheme of the bone histomorphometric parame-
ters; here,  for trabecular bone under a light microscope (repro-
duced from ref.  [13]).  Bone tissues consist of bone and bone mar-
row.  Bone is divided into 2 categories; the calcified bone (lamellar 
structure) and osteoid (black-colored zone).  BV (bone volume): the 
area of trabecular bone.  Trabecular width (W.Th) and trabecular 
thickness (Tb.Th): the width and the thickness of trabecular bone,  
respectively.  BV,  W.Th,  and Tb.Th are bone volume parameters.  
OV (osteoid volume): the area of osteoid.  O.Th (osteoid thick-
ness): the thickness of osteoid.  OS (osteoid surface): the length of 
the surface of osteoid.  Ob.S (osteoblast surface): the length of the 
surface of palisaded osteoblasts.  OV,  O.Th,  OS,  and Ob.S are 
bone formation parameters.  Fb.V (fibrosis volume): the area of 
fibrous tissue.  ES (eroded surface): the length of the invaded area 
of trabecular bone.  In an eroded surface,  the Oc.S (osteoclast sur-
face) indicates the length of the surface to which osteoclasts are 
attached.  ES,  Oc.S,  and Fb.V are bone resorption parameters.
1.6 ± 3.2 mg/day,  p = 0.29) or MTX (2.9 ± 2.9 mg/week 
vs. 2.4 ± 3.5 mg/week,  respectively; p = 0.74).  The clin-
ical characteristics are summarized in Table 1.
The average DAS28-CRP(3) score for all patients was 
2.55 ± 0.79; no significant difference was detected 
between the Des- and Fx-groups (2.55 ± 0.74 vs. 
2.54 ± 0.91,  respectively,  p = 0.95).  There were no sig-
nificant differences in the CRP,  RF,  or MMP-3 levels 
between the Des- and Fx-groups (CRP: 0.62 ± 0.75 vs. 
0.67 ± 0.65 mg/dl,  p = 0.87 ; RF : 346 ± 1,092 vs. 
263 ± 449 IU/l,  p = 0.82; and MMP-3: 159 ± 128 vs. 
140 ± 90 ng/ml,  p = 0.7,  respectively) (Table 1).
Critical histological differences were revealed 
between the 2 groups by qualitative evaluations.  In the 
Des-group,  the osteoid region was observed around the 
trabecular bone (Fig. 3A , C).  In contrast,  the trabecu-
lar bone had a sparse osteoid region around it in the 
Fx-group (Fig. 3B, D).
The bone histomorphometry results (Table 2) showed 
that the trabecular thickness (Tb.Th) was significantly 
higher in the Des-group than in the Fx-group (179± 30.8 
vs. 151 ± 23.5 μm,  p = 0.02).  However,  the bone volume 
(BV/TV) and wall thickness (W.Th) showed no signifi-
cant differences between the groups.  Both the osteoid 
volume/tissue volume (OV/TV) ratio and the osteoid 
volume/bone volume (OV/BV) ratio were significantly 
higher in the Des-group compared to the Fx-group 
(OV/TV: 0.72 ± 0.70 vs. 0.27 ± 0.32%,  p = 0.028,  and 
OV/BV: 2.96 ± 2.85 vs. 1.24 ± 1.31%,  p = 0.039).  The 
osteoblast surface area (Ob.S/BS) in the Des-group was 
remarkably higher than that in the Fx-group (9.80±10.9 
vs. 0.15 ± 0.15%,  p = 0.0005).  However,  the osteoid sur-
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Table 1　 Demographic data of femoral head cases of the destructive (Des) and fracture (Fx) groups
All cases Des-group Fx-group p-value
Cases 26 cases 28 hips 16 cases 18 hips 10 cases 10 hips










Larsen grade on radiograph in hip 













Bisphosphoate Cases 10 8 2 0.22
Methylprednisolone Cases 13 10 3 0.22







Methotrexate Cases 11 7 4 0.98







bDMARDs Cases 14 10 4 0.42
Details,  accumulated number 
of cases














DAS28CRP(3) 2.55±0.79 2.55±0.74 2.54±0.91 0.95
(1.34-4.80) (1.84-4.80) (1.34-4.35)
CRP mg/dl 0.64±0.70 0.62±0.75 0.67±0.65 0.87
(0.01-2.01) (0.01-2.00) (0.02-2.01)
RF IU/L 316±904 346±1092 263±440 0.82
(0-4610) (0-4610) (9.10-1342)
MMP-3 ng/mL 150±111 159±128 140±90 0.71
(19.90-488) (26.00-488) (19.90-297)
ABA,  abatacept; ADA,  adalimumab; bDMARDs,  biological disease-modifying anti-rheumatic drugs; DAS28CRP(3),  Disease Activity 
Score 28-C-Reactive Protein (3 joints); ETN,  etanercept; GOL,  golimumab; IFX,  infliximab; MMP-3,  matrix metalloproteinase-3; RF,  
rheumatoid factor; TCZ,  tocilizumab.
face (OS/BS) and osteoid thickness (O.Th) showed no 
significant differences between the groups.
Regarding the bone resorption parameters,  the 
osteoclast surface (N. Oc/BS) of the Des-group was sig-
nificantly higher than that of the Fx-group (0.34 ± 0.48 
vs. 0.06 ± 0.06%,  p = 0.0285).  The fibrosis volume (Fb.
V/TV) of the Des-group was also significantly higher 
than that of the Fx-group (0.16 ± 0.39 vs. 0.00 ± 0.00%,  
p = 0.01).  No significant differences were detected in the 
eroded surface (ES/BS) between the groups (Table 2).  
In addition,  the hip (femoral neck) BMD of the 
Fx-group was significantly lower than that of the Des-
group (T-scores −3.1±0.76 vs. −1.6±1.17,  p<0.01) (Fig.4).
In a coefficient analysis,  the BMD of the femoral 
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Table 2　 Comparison of the bone histomorphometry findings of femoral head cancellous bone in the Des- and Fx-groups
Parameter Abbreviation Unit General Des-group Fx-group p-value
Bone Bone volume BV/TV % 23.7±6.43 25.4±5.92 20.8±6.54 0.068
Trabecular thickness Tb.Th µm 169±31.1 179±30.8 151±23.5 0.02 ＊
Wall thickness W.Th µm 31.1±9.84 29.4±13.0 32.9±5.64 0.49
Osteoid Osteoid volume/Tissue volume OV/TV % 0.56±0.62 0.72±0.70 0.27±0.32 0.028 ＊
Osteoid volume/Bone volume OV/BV % 2.35±2.53 2.96±2.85 1.24±1.31 0.039 ＊
Osteoid surface OS/BS % 18.2±14.4 20.7±16.3 13.6±9.35 0.22
Osteoid thickness O.Th µm 10±7.3 11.6±8.26 7.09±4.21 0.069
Osteoblast surface Ob.S/BS % 6.79±10.0 9.80±10.9 0.15±0.15 0.0005 ＊＊
Resorption Eroded surface ES/BS % 1.60±2.15 1.91±2.57 0.99±0.59 0.17
Osteoclast surface Oc.S/BS % 0.25±0.41 0.34±0.48 0.06±0.06 0.0285 ＊
















Fig. 3　 Histology findings after Villanueva bone staining of subchondral cancellous bone in the femoral heads.  More osteoid (arrows) 
was attached to trabecular bone in the destructive (Des)-group (A ,C).  A small amount of osteoid was attached to trabecular bone in the 
femoral head of the fracture (Fx)-group (B ,D).  A ,B:  normal light.  C ,D: Fluorescent light.  Bar: 100 µm.  t: trabecular bone,  black or 
white arrows: osteoid bone.
neck in all cases was not closely associated with any 
bone histomorphometric parameter (bone volume,  
bone formation,  or bone resorption) (data not shown).
Discussion
The results of our present analyses demonstrated 
that the localized bone turnover in subcapital cancellous 
bone areas of destructive hip joints of patients with RA 
was much higher than that of the controls (i.e.,  the fem-
oral neck fracture group in RA) despite the low disease 
activity based on DAS28-CRP(3) scores under treat-
ment with bDMARDs.  We investigated the histomor-
phometric characteristics of cancellous bone in the 
subcapital region of the femoral heads in great detail,  
and our observations confirmed that both bone forma-
tion and resorption parameters were significantly 
increased in the destructive hip group in response to the 
destruction itself.  The hip BMD values demonstrated 
that the patients in the fracture group were more sus-
ceptible to femoral neck fractures because of the signif-
icant decrease in their BMD compared to the patients 
with destructive RA.
Shimizu et al.  evaluated the bone histomorphometry 
of the subchondral bone of 12 RA cases (10 knees,  1 
hip,  and 1 elbow) and 6 osteoarthritis (OA) cases (4 
knees and 2 hips) and they reported that a bone forma-
tion (osteoid) parameter and bone resorption parameter 
were significantly higher in the RA group compared to 
the OA group [14].  The bone histomorphometry of 3 
femoral heads from RA patients was reported; those 
data indicated that both bone formation and resorption 
parameters were more increased in the 2 destructive hip 
cases than in the single nondestructive case [15].
In the present Des-group,  since the cancellous bone 
under the articular cartilage of the hip joints had 
severely degenerated,  the values of the osteoid and 
resorption parameters were higher.  The Fb.V was also 
higher in the Des-group,  indicating high bone turn-
over; the high bone turnover state probably reflects 
hyperactive bone remodeling.  In both the Des- and 
Fx-groups,  the DAS28-CRP(3) score was comparably 
low and the disease activity of RA was well-controlled,  
which suggests that the destruction of femoral heads in 
the hips of RA patients occurs without any relation to 
their RA disease activity.  In addition,  no significant 
between-group difference was detected in the value of 
RF or MMP-3.
Another research group compared the femoral heads 
of 42 RA cases and 61 OA cases,  and they reported sig-
nificantly higher osteoid volumes in the RA group com-
pared to the OA group,  but no significant difference 
was detected between the 2 groups in bone resorption 
parameters [16].  Li et al.  examined the histomorphom-
etry findings of superficial and deep zones of the sub-
chondral bone of femoral heads in RA and OA cases,  
and they demonstrated a significantly higher ES/BS 
ratio alone in the superficial zone in RA compared to 
OA.  In the deep zone,  significant differences between 
RA and OA were not observed for any parameter,  indi-
cating that the microarchitecture of the groups was 
similar [17].  In comparison,  the ROI in our present 
study seems compatible with the deeper trabecular 
zone.  Our data indicate that (1) in RA femoral heads,  
bone resorption is increased even in the deeper trabec-
ular zone,  and (2) hip destruction (i.e.,  cartilage degen-
eration) can affect bone remodeling in the deeper zone 
of the femoral heads.
Our findings indicate that the BMD was not closely 
associated any bone histomorphometric parameter (i.e.,  
bone volume,  bone formation,  or bone resorption 
parameters).  This result suggests that the BMD of the 
femoral neck of a hip with destruction due to RA does 
not reflect the degree of destruction in femoral sub-
chondral cancellous bone turnover.  Therefore,  the 
results of a histological examination itself may be 














Fig. 4　 T-scores of the hip bone mineral density (BMD) of the 
Des- and Fx-groups.  The T-scores of the Des-group (－1.6±1.17) 
were significantly higher than those of the Fx-group (－3.1±0.76) 
(p<0.01).
important to understand the conditions of localized 
bone metabolism in RA hips.
The limitations of our study were as follows: (1) the 
small sample size,  (2) MTX and/or bDMARD treat-
ments were controlled to a high extent,  (3) the effects of 
PSL and bisphosphonates on the bone histomorpho-
metric findings were not evaluated,  and (4) double 
labeling by tetracycline was not performed,  and thus 
dynamic histomorphometry parameters could not be 
evaluated.
In conclusion,  the histomorphometry analysis of 
localized subchondral bone cancellous bone of femoral 
heads in patients with RA revealed that the osteoid and 
resorption parameters were considerably increased in 
the Des-group,  indicating that a high bone turnover 
state probably reflects hyperactive bone remodeling in 
response to the destructive changes in the hip.
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